HOWL is currently covered by 3 analysts with an average price target of $1. This is a potential upside of $0.05 (5.26%) from yesterday's end of day stock price of $0.95.
Our record on Werewolf Therapeutics covers 7 analysts since 2008; 3 cover it today. Of the 27 price targets those analysts set on HOWL, 1 were reached (4%). The highest performance score on Werewolf Therapeutics belongs to Andres Maldonado of H.C. Wainwright: 0.00, with 0 of 5 targets met. The latest calls: Robert Driscoll of Wedbush set a target of $1 with a Buy rating on 19 Dec 2025; Andres Maldonado of H.C. Wainwright updated the call with a Buy rating on 19 Dec 2025; Jason Zemansky of BofA updated the call with a Buy rating on 18 Nov 2025. Figures as of 18 Nov 2026.
Werewolf Therapeutics's activity chart (see below) currently has 34 price targets and 44 ratings on display. The stock rating distribution of HOWL is 100% BUY.
Analysts' price targets on this stock were met 7.14% of the time, taking 14.86 days on average.
Highest price target for HOWL is $1, Lowest price target is $1, average price target is $1.
Most recent stock forecast was given by ROBERT DRISCOLL from WEDBUSH on 19-Dec-2025. First documented stock forecast 25-May-2021.
Currently out of the existing stock ratings of HOWL, 3 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 24-Aug-2023
$1
$-0.01 (-0.99%)
11 months 2 days ago
(19-Dec-2025)
1/2 (50%)
$0.31 (44.93%)
104
Buy Since 27-Mar-2023
11 months 2 days ago
(19-Dec-2025)
0/5 (0%)
$11.01 (275.94%)
Buy Since 10-Sep-2021
1 years 3 days ago
(18-Nov-2025)
0/3 (0%)
$7.66 (327.35%)
Buy Since 03-Apr-2024
$3
$4
1 years 3 months ago
(21-Aug-2025)
0/5 (0%)
$1.72 (134.38%)
Buy Since 06-Jun-2023
$14
$15
2 years 8 months 14 days ago
(07-Mar-2024)
0/3 (0%)
$7.25 (107.41%)
What is HOWL (Werewolf Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on HOWL (Werewolf Therapeutics)?
Which analyst has the lowest performance score on HOWL (Werewolf Therapeutics) with a proven track record?
Which analyst has the most public recommendations on HOWL (Werewolf Therapeutics)?
Which analyst is the currently most bullish on HOWL (Werewolf Therapeutics)?
Which analyst is the currently most reserved on HOWL (Werewolf Therapeutics)?